Recognition of and treatment recommendations for oligometastatic disease in multidisciplinary tumor boards

Background and introduction: Growing evidence supports a combined modality treatment strategy for patients with oligometastatic disease. However, lack of phase III trial data and uncertainties around patient selection highlight the importance of multidisciplinary tumor boards (MDT) in therapeutic de...

Full description

Bibliographic Details
Main Authors: Sebastian M. Christ, Philip Heesen, Urs J. Muehlematter, Kaspar Pohl, Gabriel William Thiel, Jonas Willmann, Maiwand Ahmadsei, Tiuri E. Kroese, Michael Mayinger, Panagiotis Balermpas, Andreas Wicki, Nicolaus Andratschke, Martin Huellner, Matthias Guckenberger
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Clinical and Translational Radiation Oncology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405630822001070